Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9366046 | 0.93 | LMNA (0.39) | LMNA | |
| SCHEMBL21219903 | 0.86 | LMNA (0.35) | LMNA | |
| SCHEMBL28868791 | 0.84 | LMNA (0.45) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL7003138 | 0.84 | LMNA (0.39) | LMNA | |
| SCHEMBL9414024 | 0.84 | TSHR (0.37) | LMNA | |
| SCHEMBL21219894 | 0.83 | LMNA (0.36) | LMNA | |
| SCHEMBL3884739 | 0.83 | LMNA (0.31) | LMNA | |
| SCHEMBL110928 | 0.82 | LMNA (0.67) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL19392377 | 0.82 | LMNA (0.67) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL93800 | 0.82 | LMNA (0.67) | LMNABLMPTPN1MEN1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 181 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118344325-A | PI3K selective inhibitors | 轩竹生物科技股份有限公司 | 2024-07-16 | — | — | CN | disclosed |
| CN-110938104-B | Cyclic dinucleotide analogue, pharmaceutical composition and application thereof | 上海迪诺医药科技有限公司 | 2024-07-12 | — | — | CN | disclosed |
| CN-118271234-A | Piperidine derivative, composition and application thereof | 上海京新生物医药有限公司 | 2024-07-02 | — | — | CN | disclosed |
| CN-118271197-A | Cyclohexylamine derivative, and composition and application thereof | 上海京新生物医药有限公司 | 2024-07-02 | — | — | CN | disclosed |
| CN-118255760-A | Pyrimidine compound, preparation method and medical application thereof | 江苏亚虹医药科技股份有限公司 | 2024-06-28 | — | — | CN | disclosed |
| CN-112341521-B | Small molecule active compound and antibody conjugate thereof, preparation method and medical application thereof | 上海翰森生物医药科技有限公司 | 2024-06-25 | — | — | CN | disclosed |
| CN-118234742-A | Pharmaceutical composition of GLP-1 and GIP receptor dual agonist and application thereof | 江苏恒瑞医药股份有限公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-118221644-A | Pyrrolidine derivative, composition and application thereof | 上海京新生物医药有限公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-118221655-A | Heterocyclic derivative inhibitor, preparation method and application thereof | 上海翰森生物医药科技有限公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-114805462-B | Steroid derivative regulator and preparation method and application thereof | 江苏豪森药业集团有限公司 | 2024-06-18 | — | — | CN | disclosed |
| EP-3356379-B1 | PROCESS FOR PRODUCING RUTHENIUM COMPLEXES AND INTERMEDIATES THEREOF AND THEIR USE IN OLEFIN METATHESIS | APEIRON SYNTHESIS SA (PL) | 2021-03-10 | — | — | EP | disclosed |
| EP-3356379-A1 | PROCESS FOR PRODUCING RUTHENIUM COMPLEXES AND INTERMEDIATES THEREOF AND THEIR USE IN OLEFIN METATHESIS | Apeiron Synthesis S.A. (PL) | 2018-08-08 | — | — | EP | disclosed |
| EP-3294747-A1 | RUTHENIUM COMPLEXES, METHOD OF PRODUCING THEM, AND THEIR USE | Uniwersytet Warszawski (PL) | 2018-03-21 | — | — | EP | disclosed |
| WO-2016092424-A1 | RUTHENIUM COMPLEXES, METHOD OF PRODUCING THEM, AND THEIR USE | UNIWERSYTET WARSZAWSKI (PL) | 2016-06-16 | — | — | WO | disclosed |
| EP-2760581-A1 | RUTHENIUM OR OSMIUM COMPLEX, METHOD FOR ITS PREPARATION AND USE THEREOF | Instytut Chemii Organicznej Polskiej Akademii Nauk (PL) | 2014-08-06 | — | — | EP | disclosed |
| EP-2718016-A1 | NEW COMPLEXES OF RUTHENIUM, METHOD FOR THEIR PREPARATION, AND THEIR APPLICATION IN OLEFIN METATHESIS REACTIONS | Umicore AG & Co. KG (DE) | 2014-04-16 | — | — | EP | disclosed |
| WO-2013046108-A1 | RUTHENIUM OR OSMIUM COMPLEX, METHOD FOR ITS PREPARATION AND USE THEREOF | Instytut Chemii Organicznej Polskiej Akademii Nauk (PL) | 2013-04-04 | — | — | WO | disclosed |
| WO-2012168183-A1 | NEW COMPLEXES OF RUTHENIUM, METHOD FOR THEIR PREPARATION, AND THEIR APPLICATION IN OLEFIN METATHESIS REACTIONS | UMICORE AG & CO. KG (DE) | 2012-12-13 | — | — | WO | disclosed |
| WO-2010141494-A2 | SYNTHESIS OF EZETIMIBE | CODEXIS, INC. (US) | 2010-12-09 | — | — | WO | disclosed |
| US-5750540-A | SIDE EFFECT REDUCTION | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1998-05-12 | — | — | US | disclosed |